Nan Fung Trinity’s Soleno Therapeutics SLNO Stock Holding History

Nan Fung Trinity’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-126,050	Closed	-$4.22M	–	65
2026 Q1	$4.22M	Buy	126,050 +2,200	+2%	+$86.3K	0.46%	49
2025 Q4	$5.73M	Hold	123,850	–	–	0.45%	61
2025 Q3	$8.37M	Buy	123,850 +20,900	+20%	+$1.55M	0.84%	43
2025 Q2	$8.63M	Buy	+102,950	New	+$7.71M	1.03%	33

Nan Fung Trinity's SLNO Position: Q2 2026 in Review

Nan Fung Trinity sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 126,050 shares — an estimated $4.22M sold.

Nan Fung Trinity first reported a position in SLNO in Q2 2025 and held it in 4 quarters. The position peaked at $8.63M in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Nan Fung Trinity reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Nan Fung Trinity sold 126,050 Soleno Therapeutics shares in Q2 2026, an estimated $4.22M.
Nan Fung Trinity first reported a position in Soleno Therapeutics in Q2 2025 and held it in 4 quarters.
Nan Fung Trinity's Soleno Therapeutics position peaked at $8.63M in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Nan Fung Trinity's 13F filing for Q2 2026, filed 24 Jul 2026.